Prevalence of osteoporosis in patients with prostate cancer on anti-androgen therapy

被引：0
|
作者：
Senan Sanz, M. R.
Haro Iniesta, L.
Riel Cabrera, R.
Olive Ferre, F. X.
Biel Arrufat, A.
Matinero Romero, E.
机构：
来源：
SWISS MEDICAL WEEKLY | 2009年 / 139卷 / 33-34期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：151S / 151S
页数：1
相关论文
共 50 条
  • [1] Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
    Zhang, Haozhe
    Zhou, Yi
    Xing, Zengzhen
    Sah, Rajiv Kumar
    Hu, Junqi
    Hu, Hailiang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [2] Third generation anti-androgen therapy of advanced prostate cancer
    Ohlmann, C. -H.
    Kamradt, J.
    Stoeckle, M.
    UROLOGE, 2012, 51 (04): : 522 - 526
  • [3] Utilization of bone densitometry and administration of bisphosphonates to prevent osteoporosis in patients with nonmetastatic prostate cancer receiving anti-androgen therapy
    Khan, Muhammad Atif
    Holt, Abby E.
    Gujja, Swetha
    Govindarajan, Rangaswamy
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Anti-androgen monotherapy for metastatic prostate cancer
    Attard, Gerhardt
    LANCET ONCOLOGY, 2014, 15 (06): : 543 - 544
  • [5] EFFECTS OF ANTI-ANDROGEN THERAPY ON THE METASTATIC BEHAVIOR OF PROSTATE-CANCER
    HUTCHINS, GM
    DELAMONTE, SM
    MOORE, GW
    FEDERATION PROCEEDINGS, 1984, 43 (03) : 600 - 600
  • [6] Is the use of anti-androgen monotherapy appropriate in patients with advanced prostate cancer?
    Roach, M
    Reese, D
    Weinberg, V
    Small, EJ
    Carroll, PR
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 448 - 449
  • [7] Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer
    C Sanchez
    R Chan
    P Bajgain
    S Rambally
    G Palapattu
    M Mims
    C M Rooney
    A M Leen
    M K Brenner
    J F Vera
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 123 - 131
  • [8] The genomic evolution of prostate cancer under the selective pressure of anti-androgen therapy
    Gsponer, Joel Roman
    Dietsche, Tanja
    Rufle, Alexander
    Lorber, Thomas
    Juskevicius, Darius
    Perrina, Valeria
    Lenkiewicz, Elisabeth
    Zellweger, Tobias
    Bachmann, Alexander
    Barrett, Michael T.
    Rentsch, Cyrill A.
    Ruiz, Christian
    Bubendorf, Lukas
    CANCER RESEARCH, 2014, 74 (19)
  • [9] Comparison of longitudinal changes in BMD in advanced prostate cancer patients treated with androgen ablation or anti-androgen hormonal therapy
    Hussain, A
    Wadhwa, V
    Weston, R
    Parr, N
    George, E
    RHEUMATOLOGY, 2005, 44 : I7 - I8
  • [10] Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer
    Sanchez, C.
    Chan, R.
    Bajgain, P.
    Rambally, S.
    Palapattu, G.
    Mims, M.
    Rooney, C. M.
    Leen, A. M.
    Brenner, M. K.
    Vera, J. F.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (02) : 123 - 131
12345